Comparator Selection Subgroup Communique - 22 August 2019

Page last updated: 23 October 2019

The Comparator Selection subgroup met in Canberra on 22 August 2019. Attendees included representatives from Medicines Australia, the pharmaceutical industry and the Department of Health.

Members endorsed the outcomes and action items from the last meeting on 19 March 2019.

Members discussed industry’s interpretation of section 101(3B) of the National Health Act 1953 and how this is applied by the Pharmaceutical Benefits Advisory Committee. Members also brought forward a number of blue-sky solutions and an agreed position to report to the Access to Medicines Working Group meeting on 17 September 2019.

Further consideration of comparator selection issues will continue at the next meeting scheduled for November 2019.

PDF version of Comparator Selection Subgroup Communique 22 August 2019 (123 KB)